Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Merck

3 Beaten-Down Dow Stocks to Buy in October

Dow Jones industrials, such as Nike, have pulled back significantly amid recent market turmoil, and now trade at a steep discount to consensus price target estimates.

Barchart

All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

WEKU

Former Merck boss Ken Frazier wants CEOs to speak out

In a politicized world, the former Merck boss says CEOs should stand up and speak out. “Pick your spots.”

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

How To Buy MRK For A 5% Discount, Or Achieve An 13% Annual Return

Yesterday, with Merck trading at $103.94, the November put option with a strike price of $100 was trading around $1.78. Traders selling this put would receive $178 in option premium.

Barchart

Amy Klobuchar on Biden's biggest win

Minnesota senator and anti-monopoly crusader explains how fixing Medicare's drug problem will help everybody

Salon

Managers say they support skills-based hiring. But many jobs still require 4-year degrees

Just over half of hiring managers say removing four-year degree requirements would positively impact their company's hiring practices, according to a OneTen report.

Fortune

Biden names 10 drugs for first negotiations to cut Medicare prices

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial Medicare price talks. But any relief is still years away

The move is expected to cut costs in a few years for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers.

Fortune

Biden targets Jardiance, Eliquis and 8 other prescription drugs for Medicare price talks

President Joe Biden says for many Americans the cost of one drug can be “the difference between life and death” as his administration announces the first drugs that’ll be targeted for price negotiations in an effort to cut Medicare costs.

Chicago Sun-Times

HHS lists first 10 drugs subject to Medicare price negotiation - Roll Call

The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.

Roll Call

3M vs. Merck: Which Dow Dividend Stock is a Better Buy?

MMM and MRK have both underperformed markets in 2023, but offer healthy yields for value-minded investors. Which of these dividend stocks is a better pick for your portfolio right now?

Barchart

Jobs blow as science firm announces redundancies at Scottish plant

A SCOTTISH science and technology company has confirmed that "a small number" of employees are now facing redundancy.

The National (Scotland)

'The dirty disease' – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting…

The Conversation

LCD TVs are dead in the water and OLED is the future

LCD TV screens have stopped innovating, making it crystal clear OLED is the future.

TechRadar

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

Daily Record

Irvine healthcare firm plan £250,000 solar power project

North Ayrshire Council will decide on the application from Merck.

Salon

Merck sues to block lower Medicare costs

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

Reason

Merck Sues HHS, Claims Drug Price Negotiation Program Violates First and Fifth Amendment

Pharma has a "choice": Negotiate with HHS or pay $10 million "tax" per day.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Merck sues federal government, calling plan to negotiate Medicare drug prices 'extortion'

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the program a sham equivalent to extortion

Roll Call

Merck sues government over drug price negotiation - Roll Call

The lawsuit argues that the negotiation program violates the Fifth Amendment by not paying the company “just compensation” for its products.

Daily Record

New Stirling life sciences facility to bring 30 new jobs to city

Merck say “30-plus” jobs are expected to add to an existing workforce of 99.

Insider UK

Merck makes €35 million investment in Scottish sites

The expansion plan should create nearly 500 new jobs in Glasgow and Stirling

Kiplinger

Making the Case for Covered Call Strategies

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

The Conversation

Vaccines using mRNA can protect farm animals against diseases traditional ones may not – and there are safeguards to ensure they won't end up in your food

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

StockNews.com

1 Pharma Stock You'll Regret Not Buying Earlier

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

1 … 6 7 8 9

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Health and Human Services

266 stories

NKE

255 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.